William Seeley, MD

William Seeley, MD

Professor
Pathology
Specialty Areas
Neurology

UCSF
Neurology, Box 1207
675 Nelson Rising Lane, Room 211
San Francisco, CA 94158
United States

Hospital Affiliations
UCSF Mission Bay
Research and Clinical Interests

Dr. Seeley attended medical school at the University of California, San Francisco (UCSF) School of Medicine, where he first encountered patients with frontotemporal dementia (FTD) in 1999, during a research elective with Dr. Bruce Miller. He completed a neurology residency at Harvard Medical School, training at the Massachusetts General and Brigham & Women's Hospitals. Returning to UCSF for a Behavioral Neurology fellowship, Dr. Seeley developed expertise in the differential diagnosis and treatment of patients with neurodegenerative disease. Struck by the focality of these illnesses, he began to question how events at the molecular level could target small subsets of the brain's roughly 86 billion neurons. This biological problem, referred to as selective vulnerability, has become the primary focus of Dr. Seeley’s research. He addresses this question through behavioral, functional imaging and neuropathological studies. The goal of his research is to determine what makes brain tissues susceptible or resistant to disease, with an eye toward translating these findings into novel treatment approaches.

He is a Professor of Neurology and Pathology at the UCSF Memory and Aging Center and holds the Zander Family Distinguished Professor in Neurology. He is also the Director of the UCSF Neurodegenerative Disease Brain Bank.

Selected Publications
  • Abskharon R, Pan H, Sawaya MR, Seidler PM, Olivares EJ, Chen Y, Murray KA, Zhang J, Lantz C, Bentzel M, Boyer DR, Cascio D, Nguyen BA, Hou K, Cheng X, Pardon E, Williams CK, Nana AL, Vinters HV, Spina S, Grinberg LT, Seeley WW, Steyaert J, Glabe CG, Ogorzalek Loo RR, Loo JA, Eisenberg DS. Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2300258120. doi: 10.1073/pnas.2300258120. Epub 2023 Oct 6. PMID: 37801475; PMCID: PMC10576031.
  • Hua AY, Roy ARK, Kosik EL, Morris NA, Chow TE, Lukic S, Montembeault M, Borghesani V, Younes K, Kramer JH, Seeley WW, Perry DC, Miller ZA, Rosen HJ, Miller BL, Rankin KP, Gorno-Tempini ML, Sturm VE. Diminished baseline autonomic outflow in semantic dementia relates to left-lateralized insula atrophy. Neuroimage Clin. 2023;40:103522. doi: 10.1016/j.nicl.2023.103522. Epub 2023 Oct 2. PMID: 37820490; PMCID: PMC10582496.
  • Fang M, Deibler SK, Nana AL, Vatsavayai SC, Banday S, Zhou Y, Almeida S, Weiss A, Brown RH, Seeley WW, Gao FB, Green MR. Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis. Front Neurosci. 2023 Oct 2;17:1251228. doi: 10.3389/fnins.2023.1251228. PMID: 37849894; PMCID: PMC10577185.
  • Rexach JE, Cheng Y, Chen L, Polioudakis D, Lin LC, Mitri V, Elkins A, Yin A, Calini D, Kawaguchi R, Ou J, Huang J, Williams C, Robinson J, Gaus SE, Spina S, Lee EB, Grinberg LT, Vinters H, Trojanowski JQ, Seeley WW, Malhotra D, Geschwind DH. Disease-specific selective vulnerability and neuroimmune pathways in dementia revealed by single cell genomics. bioRxiv [Preprint]. 2023 Sep 30:2023.09.29.560245. doi: 10.1101/2023.09.29.560245. PMID: 37808727; PMCID: PMC10557766.
  • Lorca-Puls DL, Gajardo-Vidal A, Mandelli ML, Illán-Gala I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno-Tempini ML. Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. Brain. 2023 Sep 28:awad327. doi: 10.1093/brain/awad327. Epub ahead of print. PMID: 37769652.